{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T13:30:08Z","timestamp":1770903008172,"version":"3.50.1"},"reference-count":15,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1420,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1111\/j.1463-1318.2010.02469.x","type":"journal-article","created":{"date-parts":[[2010,10,22]],"date-time":"2010-10-22T19:30:15Z","timestamp":1287775815000},"page":"1294-1298","source":"Crossref","is-referenced-by-count":80,"title":["Surgical resection in Crohn\u2019s disease: is immunosuppressive medication associated with higher postoperative infection rates?"],"prefix":"10.1111","volume":"13","author":[{"given":"J.","family":"Canedo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.-H.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Murad-Regadas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. D.","family":"Wexner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,10,12]]},"reference":[{"key":"10.1111\/j.1463-1318.2010.02469.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1136\/gut.1.2.87","article-title":"Crohn\u2019s disease (regional enteritis) of the large intestine and its distinction from ulcerative colitis","volume":"1","author":"Lockhart-Mummery","year":"1960","journal-title":"Gut"},{"key":"10.1111\/j.1463-1318.2010.02469.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"5532","DOI":"10.3748\/wjg.14.5532","article-title":"Timing of surgery in Crohn\u2019s disease: a key issue in the management","volume":"14","author":"Alos","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1111\/j.1463-1318.2010.02469.x-BIB3|cit3","first-page":"998","article-title":"Analysis of results of surgical treatment in Crohn\u2019s disease","volume":"55","author":"Bednarz","year":"2008","journal-title":"Hepatogastroenterology"},{"key":"10.1111\/j.1463-1318.2010.02469.x-BIB4|cit4","first-page":"278","article-title":"TNF-alpha blockers in inflammatory bowel diseases: practical consensus recommendations and a user\u2019s guide","volume":"139","author":"Pache","year":"2009","journal-title":"Swiss Med Wkly"},{"key":"10.1111\/j.1463-1318.2010.02469.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/ibd.20027","article-title":"Safety of biologic therapy","volume":"13","author":"Blonski","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"10.1111\/j.1463-1318.2010.02469.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1136\/gut.42.4.470","article-title":"Increased secretion of pro-inflammatory cytokines by circulating polymorphonuclear neutrophils and regulation by interleukin 10 during intestinal inflammation","volume":"42","author":"Nikolaus","year":"1998","journal-title":"Gut"},{"key":"10.1111\/j.1463-1318.2010.02469.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1056\/NEJM199710093371502","article-title":"A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn\u2019s disease. Crohn\u2019s Disease cA2 Study Group","volume":"337","author":"Targan","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1463-1318.2010.02469.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1046\/j.1524-475x.2000.00547.x","article-title":"Inhibition of tumor necrosis factor-alpha attenuates wound breaking strength in rats","volume":"8","author":"Lee","year":"2000","journal-title":"Wound Repair Regen"},{"key":"10.1111\/j.1463-1318.2010.02469.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s00268-009-9957-x","article-title":"Effect of perioperative immunosuppressive medication on early outcome in Crohn\u2019s disease patients","volume":"33","author":"Indar","year":"2009","journal-title":"World J Surg"},{"key":"10.1111\/j.1463-1318.2010.02469.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/j.1572-0241.2004.04148.x","article-title":"Early postoperative complications are not increased in patients with Crohn\u2019s disease treated perioperatively with infliximab or immunosuppressive therapy","volume":"99","author":"Colombel","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1463-1318.2010.02469.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/j.1365-2036.2004.01904.x","article-title":"The risk of post-operative complications associated with infliximab therapy for Crohn\u2019s disease: a controlled cohort study","volume":"19","author":"Marchal","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1463-1318.2010.02469.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1007\/s11605-008-0646-0","article-title":"Use of infliximab within 3\u2003months of ileocolonic resection is associated with adverse postoperative outcomes in Crohn\u2019s patients","volume":"12","author":"Appau","year":"2008","journal-title":"J Gastrointest Surg"},{"key":"10.1111\/j.1463-1318.2010.02469.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1007\/s11605-008-0630-8","article-title":"Perioperative treatment with infliximab in patients with Crohn\u2019s disease and ulcerative colitis is not associated with an increased rate of postoperative complications","volume":"12","author":"Kunitake","year":"2008","journal-title":"J Gastrointest Surg"},{"key":"10.1111\/j.1463-1318.2010.02469.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/ibd.3780050209","article-title":"Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results, and safety","volume":"5","author":"Sandborn","year":"1999","journal-title":"Inflamm Bowel Dis"},{"key":"10.1111\/j.1463-1318.2010.02469.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1007\/s10350-008-9364-7","article-title":"Infliximab in ulcerative colitis is associated with an increased risk of postoperative complications after restorative proctocolectomy","volume":"51","author":"Mor","year":"2008","journal-title":"Dis Colon Rectum"}],"container-title":["Colorectal Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1463-1318.2010.02469.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1463-1318.2010.02469.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T03:50:19Z","timestamp":1625543419000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1463-1318.2010.02469.x"}},"subtitle":["Surgical resection in Crohn\u2019s disease"],"short-title":[],"issued":{"date-parts":[[2011,10,12]]},"references-count":15,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,11]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1463-1318.2010.02469.x","relation":{},"ISSN":["1462-8910"],"issn-type":[{"value":"1462-8910","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10,12]]}}}